Amphotericin B and coccidioidomycosis

Annals of the New York Academy of Sciences

Volumn 1111, Issue , 2007, Pages 434-441

  Johnson, Royce H ^a   Einstein, Hans E ^a  

^a KERN MEDICAL CENTER   (United States)

Author keywords

Amphotericin B; Coccidioidomycosis; Therapy

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AMPHOTERICIN B METHYL ESTER; DIPHENHYDRAMINE; FLUCONAZOLE; MAGNESIUM; METOCLOPRAMIDE; PARACETAMOL; PETHIDINE; POTASSIUM; PYRROLE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANEMIA; ANOREXIA; CARDIOMYOPATHY; CLINICAL PRACTICE; COCCIDIOIDOMYCOSIS; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SYNTHESIS; FEVER; GOLD STANDARD; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXIA; KIDNEY INJURY; LUNG INFECTION; MENINGITIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PREGNANCY; RIGOR; SIDE EFFECT; SYNOVITIS; VOMITING;

EID: 35348926847     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1406.019     Document Type: Conference Paper

References (36)

1. FIESE, M.J. 1958. Coccidioidomycosis. 182. Charles C Thomas: Springfield, IL.
2. COHEN, R. 1955. A new fungicide for coccidioidomycosis. Arch. Pediat. 72: 154-155.
3. WINN, A. 1959. The use of amphotericin B in the treatment of coccidioidal disease. Sem. Mycotic Infect. 3: 617-635.
4. EINSTEIN, H.E. & R.H. JOHNSON. 1993. Coccidioidomycosis: new aspects of epidemiology and therapy. CID 16: 349-356.
5. GROLL, H. & T.J. WALSH. 2000. Polyene antifungal agents. In Fungal Diseases of the Lung, third edition 17: 271-277.
6. BRAJTBURG, J. & J. BOLARD. 1996. Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev.. 9: 512-531.
7. SAU, K., et al. 2003. The antifungal drug amphotericin B promotes inflammatory cytokine release by a toll-like receptor and CD14-dependent mechanism. J. Biol. Chem. 278: 37561-37568.
8. STEIN, R.S. et al. 1965. Treatment of coccidioidomycosis infection of bone with local amphotericin B suction-irrigation. Case Reports 108: 161-164.
9. UTZ, J.P. 1967. Recent experience in the chemotherapy of the systemic mycoses. In Coccidioidomycosis. L. Ajello, Ed.: 113-117. University of Arizona Press. Tucson.
10. GRAYBILL, J.R. et al. 1988. Ketoconazole treatment of coccidioidal meningitis. Ann. N.Y. Acad. Sci. 544: 488-496.
11. GALGIANI, J.N. et al. 2000. Comparison of oral fluconazole and itraconazole for progressive, non-meningeal coccidioidomycosis: a randomized, double-blind trial. Ann. Int. Med. 133: 676-686.
12. IGER, M. & J. LARSON. 1967. Coccidioidal osteomyelitis. In Proceedings of Coccidioidomycosis. (Second Coccidioidomycosis Symposium). L. Ajello, Ed.: 89-92. University of Arizona Press. Tucson.
13. HOEPRICH, P.D. et al. 1988. Treatment of fungal infections with semisynthetic derivatives of amphotericin B. Ann. N. Y. Acad. Sci. 544: 517-546.
14. LAWRENCE, R.M. & P.D. HOEPRICH. 1976. Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis. J. Infect. Dis. 133: 168-174.
15. HOEPRICH, P.D. 1982. Amphotericin B methyl ester and leukoencephalopathy: the other side of the coin. J. Infect. Dis. 146: 173-175.
16. ELLIS, W.G. et al. 1982. Leukoencephalopathy in patients treated with amphotericin B methyl ester. J. Infect. Dis. 146: 125-137.
17. CLEMONS, K.V. et al. 2001. A novel heparin-coated hydrophilic preparation of amphotericin B hydrosomes. Curr. Opin. Invest. Drugs 2: 480-487.
18. GONZALEZ, G.M. et al. 2004. Efficacy of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis. Antimicrob. Agents Chemother. 48: 2140-2143.
19. CLEMONS, K.V. & D.A. STEVENS. 1992. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis. J. Antimicrob. Chemother. 30: 353-363.
20. CLEMONS, K.V. & D.A. STEVENS. 1991. Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis. Antimicrob. Agents Chemother. 35: 1829-1833.
21. CLEMONS, K.V. et al. 2002. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrob. Agents Chemother. 46: 2420-2426.
22. KOEHLER, A.P. et al. 1996. Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. Case Reports 95: 113-115.
23. ANTONY, S. et al. 2003. Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis. J. Natl. Med. Assoc. 95: 982-985.
24. ARSURA, E.L. et al. 1994. Amphotericin B-induced dilated cardiomyopathy. Am. J. Med. 97: 560-562.
25. DANAHER, P.J. et al. 2004. Reversible dilated cardiomyopathy related to amphotericin B therapy. J. Antimicrob. Chemother. 53: 115-117.
26. WALSH, T.J. et al. 1999. N. Engl. J. Med. 340: 764.
27. OSTROSKY-ZEICHNER, L. et al. 2003. Amphotericin B: time for a new "gold standard": reviews of anti-infective agents. CID 37: 415-425.
28. REYNOLDS, E.S. et al. 1963. The renal lesion related to amphotericin B treatment for coccidioidomycosis. Med. Clin. North Am. 47: 1149-1154.
29. IOVINE, G. et al. 1963. Nephrotoxicity amphotericin B. Arch. Intern. Med. 112: 853-862.
30. ZAGER, R.A. et al. 1992. Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents. Kidney Int. 41: 1588-1594.
31. MCCHESNEY, J.A. & J.F. MARQUARDT. 1964. Hypokalemic paralysis induced by amphotericin B. 189: 1029-1031.
32. TAKACS, F.J. et al. 1968. Amphotericin B nephrotoxicity with irreversible renal failure. Case Study 59: 716-724.
33. HOLEMAN, C.W., JR. & H. EINSTEIN. 1963. The toxic effects of amphotericin B in man. Calif. Med. 99: 90-93.
34. GALGIANI, J.N. et al. 2005. Coccidioidomycosis. CID 41: 1217-1223.
35. SPINELLO, I.M. & R.H. JOHNSON. 2006. A 19-year-old pregnant woman with a skin lesion and respiratory failure. Chest Cardiopulm. Crit. Care J. 130: 611-15.
36. STEVENS, D.A. & S.A. SHATSKY. 2001. Intrathecal amphotericin in the management of coccidioidal meningitis. Sem. Resp. Infect. 16: 263-269.